Active substanceAmylmetacresol + Dichlorobenzyl alcoholAmylmetacresol + Dichlorobenzyl alcohol Similar drugsTo uncover Agicept® pills inwards Agio Pharmaceuticals Ltd. India Agicept® pills inwards Agio Pharmaceuticals Ltd. India Astracept® lozenges inwards Enzyme Biotech Co., Ltd. India Hexoral® tabs classic pills inwards Johnson & Johnson, LLC Russia Koldakt Lorpils pills inwards Ranbaxy Laboratories Limited India Strepsils® pills locally inwards Rekitt Benckiser Helsar International Ltd. United Kingdom Strepsils® with cooling effect pills locally inwards Rekitt Benckiser Helsar International Ltd. United Kingdom Strepsils® with Warming Effect pills locally inwards Rekitt Benckiser Helsar International Ltd. United Kingdom Suprima-LOR® pills inwards Shraya Life Senses Pvt. Ltd. India Terasil pills locally Plethiko Pharmaceuticals Co., Ltd. India Dosage form: & nbsplemon and orange absorbtion tablets Composition:Active Ingredients: 2,4-dichlorobenzyl alcohol - 1.2 mg; amylmethacresol 0.6 mg. Excipients: levomenthol, orange oil, lemon oil, dye San set yellow PCP, dye quinoline yellow WS, citric acid anhydrous, sucrose, liquid glucose, purified water. Description:Orange absorbing tablets: Round, orange-colored tablets with the scent of orange.Tablets for resorption lemon: Round, yellow tablets with lemon flavor. Pharmacotherapeutic group:Antiseptic ATX: & nbspR.02.A.A Antiseptics Pharmacodynamics:Combined antiseptic preparation for topical application in the oral cavity and pharynx. Has an antiseptic effect. It is active against gram-positive and gram-negative microorganisms.Data on the pharmacokinetics of the drug Koldact® Lörpils are absent. Indications:Infectious and inflammatory diseases of the oral cavity and pharynx. Contraindications:Hypersensitivity to the components of the drug. Children under 12 years. Dosing and Administration:Adults take 1 tablet every 2 hours.The maximum daily dose is 8 tablets.Children over 12 years of age are prescribed 1 tablet every 4 hours.The maximum daily dose is 6 tablets.Tablets dissolve until complete dissolution. Side effects:When used according to the indications in recommended doses, the side effect of the drug was not noted. Interaction:The interaction of the drug Koldact® Lörpils with drugs of other groups has not been studied. Special instructions:When prescribing a drug for patients with diabetes it is necessary to take into account that each tablet contains 2.4 g of sugar. Form release / dosage:Tablets for resorption lemon, orange. Packaging:For 4 tablets in contour non-jammed packaging from aluminum foil, 5 packs in a cardboard box with instructions for use. Storage conditions:Store at a temperature not higher than 25 ° C, protected from moisture.Keep out of the reach of children. Shelf life:3 years. Do not use after the date shown on the package. Terms of leave from pharmacies:Without recipe Registration number:П N015102 / 01 Date of registration:02.10.2008 Expiration Date:Unlimited The owner of the registration certificate:Ranbaxy Laboratories LimitedRanbaxy Laboratories Limited India Manufacturer: & nbspMAKSON PHARMACEUTICALS, (I) P.Ltd. India Representation: & nbspRABBAYS LABORATORY LIMITEDRABBAYS LABORATORY LIMITED Information update date: & nbsp31.01.2018 Illustrated instructions × Illustrated instructions Instructions